When prognosis precedes diagnosis: putting the cart before the horse

Sabatine, Marc S.
June 2005
CMAJ: Canadian Medical Association Journal;6/21/2005, Vol. 172 Issue 13, p1697
Academic Journal
Comments on a study concerning the use of ischemia-modified albumin (IMA) as a biomarker for acute coronary syndrome. Overview of the study; Background on IMA.


Related Articles

  • Ischemia-modified albumin use as a prognostic factor in coronary bypass surgery.  // Journal of Cardiothoracic Surgery;2012, Vol. 7 Issue 1, p3 

    The article presents a study related to ischemia-modified albumin (IMA) for the diagnosis in the early stages of ischemia, before the development of necrosis. It included 30 patients that underwent coronary bypass surgery due to ischemic heart disease. IMA levels were analyzed in the...

  • Capability of ischemia-modified albumin to predict serious cardiac outcomes in the short term among patients with potential acute coronary syndrome. Worster, Andrew; Devereaux, P. J.; Heels-Ansdell, Diane; Guyatt, Gordon H.; Opie, John; Mookadam, Farouk; Hill, Stephen A. // CMAJ: Canadian Medical Association Journal;6/21/2005, Vol. 172 Issue 13, p1685 

    Abstract Background Ischemia-modified albumin (IMA) has been suggested as a marker of cardiac ischemia. Little, however, is known about its capacity to predict short-term serious cardiac outcomes (death, myocardial infarction, congestive heart failure, serious arrhythmia, or refractory ischemic...

  • Curbing Inflammation in the Ischemic Heart Disease. Evora, Paulo Roberto B.; Nather, Julio; Tubino, Paulo Victor; Albuquerque, Agnes Afrodite S.; Celotto, Andrea Carla; Rodrigues, Alfredo J. // International Journal of Inflammation;2013, p1 

    A modern concept considers acute coronary syndrome as an autoinflammatory disorder. From the onset to the healing stage, an endless inflammation has been presented with complex, multiple cross-talk mechanisms at the molecular, cellular, and organ levels. Inflammatory response following acute...

  • Cardiac troponin T elevation after stroke: The relationships between elevated serum troponin T, stroke location, and prognosis. Yong Bum Kim // Annals of Indian Academy of Neurology;Nov2008 Supplement, Vol. 11, pS164 

    Background: Serum cardiac troponin T (cTnT) is regarded as a specific marker of acute coronary syndrome. However, increased cTnT is sometimes identified in patients with acute ischemic stroke. The aim of the present study was to identify the relationships between elevated serum cTnT and stroke...

  • Potential value for new diagnostic markers in the early recognition of acute coronary syndromes. Lippi, Giuseppe; Montagnana, Martina; Salvagno, Gian Luca; Guidi, Gian Cesare // CJEM: Canadian Journal of Emergency Medicine;Jan2006, Vol. 8 Issue 1, p27 

    The diagnostic approach to acute coronary syndromes (ACS) remains one of the most difficult and controversial challenges facing emergency physicians. In recent years, cardiac troponins have emerged as the biochemical "gold standard" for diagnosis of patients with acute chest pain, enhancing our...

  • Translational phases of evidence in a prognostic biomarker: a systematic review and meta-analysis of natriuretic peptides and the prognosis of stable coronary disease. Sutaria, Shailen; Philipson, Peter; Fitzpatrick, Natalie K.; Abrams, Keith; Moreno, Santiago G.; Timmis, Adam; Hingorani, Aroon D.; Hemingway, Harry // Heart;Apr2012, Vol. 98 Issue 8, p615 

    Context Translational phases of study are important in evaluating whether a prognostic biomarker is likely to have impact on clinical practice but systematic evaluations of such evidence are lacking. Objective To systematically evaluate the clinical usefulness of the published literature on the...

  • Proteomic risk markers for coronary heart disease and stroke: Validation and mediation of randomized trial hormone therapy effects on these diseases. Prentice, Ross L.; Shanshan Zhao; Johnson, Melissa; Aragaki, Aaron; Hsia, Judith; Jackson, Rebecca D.; Rossouw, Jacques E.; Manson, JoAnn E.; Hanash, Samir M. // Genome Medicine;2012, Vol. 4 Issue 12, p1 

    Background We previously reported mass spectrometry-based proteomic discovery research to identify novel plasma proteins related to the risk of coronary heart disease (CHD) and stroke, and to identify proteins with concentrations affected by the use of postmenopausal hormone therapy. Here we...

  • Suppression of Myocardial Injury Markers following Percutaneous Coronary Interventions by Pre-treatment with Carvedilol. Moloudi, Abdolrasoul; Sabzi, Feridoun; Rashidi, Shirin // International Cardiovascular Research Journal;2012, Vol. 6 Issue 3, p88 

    Background: Retrospective studies and clinical trials have indicated that β-receptor blockers have an influential role in improving survival and reducing risk of recurrent infarction in patients with myocardial infarction. However, there is still controversy regarding the effects of...

  • Biochemical markers in acute ischemic stroke. Hill, Michael D.; Jackowski, George; Bayer, Neville; Lawrence, Mitzi; Jaeschke, Roman // CMAJ: Canadian Medical Association Journal;4/18/2000, Vol. 162 Issue 8, p1139 

    Advocates the use of biochemical tests to diagnose ischemic stroke. Clinical trial testing a panel of biochemical markers that include neuron-specific enolase (NSE) and myelin basic protein (MBP) in blood samples of acute ischemic stroke patients; Results of elevated levels of NSE in patients;...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics